Cargando…
Research progress of antibody-drug conjugates therapy for HER2-low expressing gastric cancer
Gastric cancer (GC) is a highly fatal malignant tumor in the world. Most of the patients are in an unresectable state when they have symptoms. Systemic treatment is the primary treatment for advanced patients. Among them, the Human epidermal growth factor receptor 2 (HER2) is an important therapeuti...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860488/ https://www.ncbi.nlm.nih.gov/pubmed/36652760 http://dx.doi.org/10.1016/j.tranon.2023.101624 |